Despite the growth of specialist companies with capabilities across various therapeutic areas in Europe, there is still a need for early development expertise with end-to-end pharmaceutical manufacturing capabilities.
Jon Sutch
Advertisement
Jon Sutch, PhD, is manager of formulation development at Patheon’s Milton Park facility, UK, [email protected].
Articles by Jon Sutch
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Viral Safety 2.0: Plant-Ready Actions for ICH Q5A(R2) Compliance
2
Renewing Prosaic Generics for Cancer Treatment
3
Faster Doesn’t Mean Easier: Development Impacts of a New Biosimilar Regulatory Landscape
4
Leveraging an Innovative Mid-Scale Manufacturing Solution to Meet Diverse Needs
5